Cargando…

The Latin American Association of Cardiac and Endovascular Surgery statement regarding the recently released 2020 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Dayan, Victor, Garcia-Villarreal, Ovidio A, Escobar, Alejandro, Ferrari, Javier, Quintana, Eduard, Marin-Cuartas, Mateo, Almeida, Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083943/ https://www.ncbi.nlm.nih.gov/pubmed/33576782 http://dx.doi.org/10.1093/ejcts/ezab027

Ejemplares similares

The Latin American Association of Cardiac and Endovascular Surgery statement regarding the recently released 2020 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease
por: Dayan, Victor, et al.
Publicado: (2021)

The official position of the Latin American Association of Cardiac and Endovascular Surgery (LACES) regarding the recently released SOLACI/SIAC Clinical Guidelines on TAVI versus SAVR
por: Dayan, Victor, et al.
Publicado: (2021)

The South American Society of Cardiology (SSC) and the Latin American Association of Cardiac and Endovascular Surgery (LACES) Statement on the 2021 ACC/AHA/SCAI Guidelines for Coronary Artery Revascularization
por: Soca, Gerardo, et al.
Publicado: (2023)

MitraClip for Secondary Mitral Regurgitation: Approach to the 2020 ACC/AHA Valvular Heart Disease Guidelines
por: McCauley, Brian D., et al.
Publicado: (2020)

Perspectives in Training and Professional Practice of Cardiac Surgery in Latin America
por: Marin-Cuartas, Mateo, et al.
Publicado: (2023)

What is new in ACC/AHA 2017 focused update of valvular heart disease guidelines
por: Özkan, Mehmet
Publicado: (2017)

COVID-19 and Cardiovascular Surgery. Do We Know What We Are Dealing With?
por: Almeida, Rui M. S., et al.
Publicado: (2021)

Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19
por: Bozkurt, Biykem, et al.
Publicado: (2020)

AHA/ACC/Multisociety Cholesterol Guidelines: highlights
por: Jialal, Ishwarlal, et al.
Publicado: (2019)

The 2020 American College of Cardiology/American Heart Association (ACC/AHA) Guideline for the Management of Patients with Valvular Heart Disease. Should the World Jump In?
por: Gomes, Walter J, et al.
Publicado: (2021)

Comparison of ESC and ACC/AHA guidelines for myocardial revascularization
por: Stirrup, Jim, et al.
Publicado: (2017)

Representation of cardiovascular magnetic resonance in the AHA / ACC guidelines
por: von Knobelsdorff-Brenkenhoff, Florian, et al.
Publicado: (2017)

Management of the ACC/AHA Stage D Patient: Cardiac Transplantation
por: Kittleson, Michelle M., et al.
Publicado: (2014)

2021 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions)
por: Creager, Mark A., et al.
Publicado: (2021)

Machine Learning Outperforms ACC/AHA CVD Risk Calculator in MESA
por: Kakadiaris, Ioannis A., et al.
Publicado: (2018)

Are the guidelines of the ISH devoted to a population not contemplated in the ACC/AHA guidelines?
por: Ruilope, Luis M., et al.
Publicado: (2020)

Incident cerebral microbleeds and hypertension defined by the 2017 ACC/AHA Guidelines
por: Xia, Yiwei, et al.
Publicado: (2021)

Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline
por: Cardoso, Rhanderson, et al.
Publicado: (2022)

2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals
Publicado: (2016)

2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals
por: Egan, Brent M., et al.
Publicado: (2016)

Validation of the 2020 AHA/ACC Risk Stratification for Sudden Cardiac Death in Chinese Patients With Hypertrophic Cardiomyopathy
por: Dong, Yan, et al.
Publicado: (2021)

Recalibration of the ACC/AHA Risk Score in Two Population-Based German Cohorts
por: de las Heras Gala, Tonia, et al.
Publicado: (2016)

Implications of the ACC/AHA risk score for prediction of heart failure: the Rotterdam Study
por: Arshi, Banafsheh, et al.
Publicado: (2021)

ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison
por: Behnoush, Amir Hossein, et al.
Publicado: (2022)

Estimated Change in Prevalence of Hypertension in Nepal Following Application of the 2017 ACC/AHA Guideline
por: Kibria, Gulam Muhammed Al, et al.
Publicado: (2018)

Female‐friendly focus: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
por: Wenger, Nanette K.
Publicado: (2019)

Prevalence of high blood pressure in Iranian adults based on the 2017 ACC/AHA guideline
por: Hosseini, Mostafa, et al.
Publicado: (2019)

Society for Cardiovascular Magnetic Resonance perspective on the 2021 AHA/ACC Chest Pain Guidelines
por: Arai, Andrew E., et al.
Publicado: (2022)

Comparison of the ACC/AHA and Framingham algorithms to assess cardiovascular risk in HIV-infected patients
por: Pinto Neto, Lauro Ferreira da Silva, et al.
Publicado: (2017)

External validation of the ACC/AHA ASCVD risk score in a Colombian population cohort
por: Rodríguez-Ariza, Carlos Daniel, et al.
Publicado: (2023)

Adherence to the 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline on the Use of Oral Anticoagulant Agents in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study
por: Hammoudeh, Ayman J., et al.
Publicado: (2021)

The 2017 ACC/AHA stage 1 hypertension is associated with arterial stiffness: a prospective analysis
por: Liu, Shanshan, et al.
Publicado: (2021)

Prevalence of and factors associated with hypertension according to JNC 7 and ACC/AHA 2017 guidelines in Bangladesh
por: Rahman, Md. Ashfikur, et al.
Publicado: (2021)

Thoracic Aortic Calcification and Pre-Clinical Hypertension by New 2017 ACC/AHA Hypertension Guidelines
por: Jan, Ya-Ting, et al.
Publicado: (2021)

2021 ACC/AHA/SCAI Coronary Artery Revascularization Guidelines for Managing the Nonculprit Artery in STEMI
por: Don, Creighton W., et al.
Publicado: (2022)

Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC/AHA guidelines
por: Matyori, Amro, et al.
Publicado: (2023)

The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention
por: Abovich, Arielle, et al.
Publicado: (2023)

Implication of thoracic aortic calcification over coronary calcium score regarding the 2018 ACC/AHA Multisociety cholesterol guideline: results from the CAC Consortium
por: Han, Donghee, et al.
Publicado: (2021)

Doctors’ knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore
por: Setia, Sajita, et al.
Publicado: (2015)

Blood Pressure Control and Cardiovascular Outcomes: Real-world Implications of the 2017 ACC/AHA Hypertension Guideline
por: Lee, Ji Hyun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8gjkjtubqsmu8ff3t4dnpu5opt